The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan by unknown
The Hyaluronan Receptor (CD44)Participates
inthe Uptake and Degradation ofHyaluronan
Martine Culty, Huong A. Nguyen, and Charles B. Underhill
Department of Anatomy and Cell Biology, Georgetown Medical Center, Washington, DC 20007
Abstract. The hyaluronan receptor belongs to the
polymorphic family of CD44 glycoproteins, which
have been implicated in a variety of cellular functions
including adhesion to hyaluronan and collagen, the
binding of lymphocytes to high endothelial cells dur-
ing extravasation, and conferring metastatic potential
to carcinoma cells. Here, we demonstrate that the
receptor also participates in the uptake and degrada-
tion of hyaluronan by both transformed fibroblasts
(SV3T3 cells) and alveolar macrophages. These cells
were incubated with isotopically labeled hyaluronan
for various periods of time, and the extent of degrada-
tion was determined by either molecular-sieve chroma-
tography or centrifugation through Centricon 30
microconcentrators. The macrophages degraded the
hyaluronan at a faster rate than the SV3T3 cells,
which may reflect the fact that they contained a
greater number of receptors. More importantly, in
T
HE hyaluronan receptor is a cell-surface glycoprotein
of 85-100 kD, which recognizes a six sugar sequence
of hyaluronan and mediates the divalent-cation inde-
pendent aggregation of cells (32, 33, 34, 35, 39) . Indeed,
mAbs to this receptor specifically block the hyaluronan-
induced aggregation of both cultured fibroblasts and mac-
rophages (12) . Biochemical studies of this receptor have
revealed that it is an elliptical glycoprotein which is phos-
phorylated and has a high negative charge (4, 33, 39). In ad-
dition, its cytoplasmic domain appears to be associated with
actin filaments (16), perhaps through an ankyrin-like mole-
cule (15). This receptor is present on a wide variety of cells
including most epithelial cells, macrophages and lympho-
cytes (l, 11, 33) . Interestingly, in the case of epithelia, it is
preferentially expressed on those cellsundergoing active cell
division (1).
Recently, a number of studies have shown that the hyaluro-
nan receptor is identical to CD44, which has been impli-
cated in the homing oflymphocytes to mucosal lymphoid tis-
sues (2, 4, 19, 22). CD44 on the surfaces of lymphocytes
binds to a protein termed mucosal addressin, which is pres-
ent on the high-endothelial cells of gut-associated lymphoid
tissues (14, 23, 28, 30). However, the ability of CD44 to bind
addressin is distinct from its ability to bind hyaluronan. In-
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both cell types, the degradation of hyaluronan was
specifically blocked by antibodies directed against the
receptor. However, the receptor by itself did not have
the ability to degrade hyaluronan, since preparations
of SV3T3 membranes containing the receptor did not
break down hyaluronan. Subsequent experiments re-
vealed that macrophages can internalize fluorescein-
tagged hyaluronan, and this process was blocked by
antibodies against the receptor. Furthermore, the sub-
sequent degradation of hyaluronan was inhibited by
agents that block the acidification of lysosomes (chlo-
roquine and NH4C1). Thus, the most likely explanation
for these results is that the receptor mediates the up-
take of hyaluronan into the cell where it can be
degraded by acid hydrolases in lysosomes. The ability
of cells expressing the receptor to degrade hyaluronan
may be important during tissue morphogenesis and
cell migration .
deed, sequence analysis of the receptor (CD44) molecule
has revealed that its extracellular domain is composed of two
distinct regions; an N112-terminal region, which is homolo-
gous to the link protein ofcartilage and presumably mediates
the binding ofhyaluronan, and a more medial region, which
is responsible for the binding to vascular addressin (4, 28) .
Thus, the hyaluronan receptor (CD44) is an example of a
protein which can bind to multiple ligands and carry out
different functions.
In this study, we present evidence that this protein also par-
ticipates in the degradation of hyaluronan. More specifically,
cultured fibroblasts and macrophages can degrade hyaluro-
nan, and this process is blocked by antibodies directed
against the receptor. This ability to degrade hyaluronanmay
be an important factor during embryonic development and
other processes in which hyaluronan is lost from the matrix
in a highly ordered fashion.
MaterialsandMethods
AssayforPHJHyaluronan Degradation
The mouse SV3T3 cells were grown and cultured in 10% NuSerum (Col-
laborativeResearch, Lexington, MA), 90% DME, plus 100 U/ml penicillin
1055and100 wg/ml streptomycin as described previously (40), while thealveolar
macrophageswere collected by lavage oflungs fromadult hamsters (Charles
River, Wilmington, MA) and maintained in 10% FCS, 90% McCoy's
medium plus 50 gg/ml gentamicin. In initial experiments, the cells were
cultured in media containing [3H]hyaluronan (2 pg/ml). After 40 h, the
medium was removed and the cell layer was digested overnight with 20
mg/ml pronase E (Sigma Chemical Co., St. Louis, MO), which had been
predialyzed against distilled water to remove Ca' salts along with NaN3
as a preservative. The cell layer digest was then recombined with the
medium and further incubatedfor several hours. Thedigest was lyophilized,
reconstituted in 1 ml of calcium- and magnesium-free PBS (CMF-PBS)1 ,
and applied to a 1.5X 110-cm column ofSephadex G-15 (Pharmacia, Pis-
cataway, NJ). The column was eluted with CMF-PBS and 2-ml fractions
were collected. The column was standardized with [3H]glucosamine, [3H]
H2O and various oligosaccharide fragments of hyaluronan which were de-
tected by the uronic acid assay of Bitter and Muir (3).
In subsequent experiments, the extent of [3H]hyaluronan degradation
was determined by passage through a size-specific membrane. For this, the
cells were suspended in culture medium, and1-ml aliquots were distributed
into a 24 multi-well plate to which was added 2 jug/ml of [3H]hyaluronan
along with the various agents to be tested. At the end of the incubation, the
cultures were digested with pronase E (200 Ad of a 20-mg/ml solution) as
described above and applied onto Centricon 30 Microconcentrators (Anti-
con, Danvers, MA). After centrifugation, the material passing through the
membrane was collected and processed for scintillation counting. Con-
trol experiments demonstrated that this protocol gave similar results to
molecular-sieve chromatography for determining the degradation of [3H]-
hyaluronan. In each case, the background level of degradation was deter-
mined by incubating [3H]hyaluronan in a cell-free medium for the appro-
priate length oftime. This value varied from 25 to 200cpm for the SV3T3
cells and 60 to 1,000 cpmfor the macrophages, depending upon the incuba-
tion time and the particular medium used.
AssayforPH]Hyaluronan BindingActivity
Hyaluronan binding activity was determined using a modified version of
that previously described (4, 38). The samples were dissolved in 200ill of
0.1% Na deoxycholate, 0.5 M NaCl, 0.02 M Tris, pH 8.0 (DOC buffer), to
which was added 1 t gof [3H]hyaluronan and the volume was adjusted to
250 ul. After shaking for at least 20 min, 250 A1 of saturated (NH4)2SO4
wasadded followed by 25 A1 of nonfat milk and then the samples were cen-
trifuged at 9,000 g for 5 min. Thetubes were rinsed twice with 50% satu-
rated (NH4)2SO4 and the pellets were dissolved in water andprocessed for
scintillation counting. Thebackground level of binding wasdetermined by
including an excess of nonlabeled hyaluronan (60 ug) in the initial assay
mixture.
Isolation ofSV-373 Membranes
To determine if the receptor itself has hyaluronidase activity, membranes
were examined for their ability to degrade hyaluronan. Approximately 1.5
x 108 SV3T3 cells were suspended in a solution of0.02% EDTA in CMF-
PBSand centrifuged to pellet the cells. Thepellet was resuspended in 5 ml
of 10 mM Na2HPO4, 1 mM PMSF, pH 7.3, and maintained for 20 minon
ice. The cells were then lysed using a Potter-Elvejhem homogenizer, and
mixed with 2 vol of 20 mM Tris, 500 mM sucrose, 1 mM PMSF. The
homogenate was subjected to low speed centrifugation (2,000 g, 15 min)
to remove nuclei and unlysed cells, and the resulting supernatant was
centrifuged at high speed (100,000 g, 30 min) to pellet the membrane-
containing fraction. The membrane preparation was analyzed for [3H]-
hyaluronan binding activity and protein content. Aportion of the prepara-
tion was suspended in culture medium along with [3H]hyaluronan and
analyzed for degradation as described above.
FluorescentMicroscopy
Alveolar macrophages were suspended in 10% FCS, 90% McCoy's
medium, and then 300-pl aliquots were distributed to the wells of cham-
bered slides (eight chambers, LabTek). For the experiments involving the
fluorescein-tagged hyaluronan, thecells were pretreated for 15 minwith the
following agents; K-3 mAb(20 lAg/ml); control mouse IgG(20 Ag/ml); Fab
fragment of the K-3 mAb (20 pg/ml); and hyaluronan (1 mg/ml, Type I,
1. Abbreviations used in this paper: b-K-3 mAb, biotinylated K-3 mAb;
CMF-PBS, calcium- and magnesium-free PBS.
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Sigma Chemical Co.). Next, the fluorescein-tagged hyaluronan (100 ILg/ml)
was added to the wells and the cultures were maintained at 37°C for the
indicated period of time. Theslides were washed with PBS, fixed for 3 min
in methanol at -20°C, and mounted in glycerol/PBS (Citifluor). Thecells
were photographed on an Olympus Microscope equipped with epifluores-
cent optics using the fluorescein filter cube. For staining with the b-K-3
mAb, the cells were fixed in formalin, and then incubated with 4 Pg/nil
b-K-3 mAbin 10% calf serum, 90% CMF-PBS, followed by a 1 to 50 dilu-
tion of FITC-Streptavidin (Zymed, South San Francisco, CA). The slides
were mounted and photographed as described above. In each case, repre-
sentative cells were photographed. However, macrophages that contained
large autofluorescent granules (easily distinguished by their yellow color)
as well as cells which were clearly not macrophages were excluded.
PreparationofBiochemicals
TheK-3 mAbis a mouse IgGdirected againstthehamsterhyaluronan recep-
tor (36), which blocks the binding of hyaluronan to receptors from both
hamsters and mice (12). It wasisolated from ascites fluid by chromatogra-
phy on aprotein A-Sepharose (Sigma Chemical Co.) using the Monopure
buffer system (Pierce Chemical Co., Rockford, IL). Thecontrol consisted
ofIgGisolated from pooled mouse serum. Thepurified K-3 mAbwas cou-
pled to biotin (b-K-3) using sulfosuccinimidyl 6-(biotinamido) hexanoate
(Pierce Chemical Co.) as previously described (1, 41). Fab fragments of the
K-3 mAbwere prepared by digesting the purified K-3 mAb with immobi-
lized papain according to the method provided by the Pierce Chemical Co.
The Fab fragments were purified by chromatography on a protein A-Seph-
arose column.
TheKM-201 mAbis a rat IgG directed against the hyaluronan receptor
from mouse, which blocks the binding of hyaluronan to the receptor from
both mouse and hamster cells (4, 22). This mAb was purified from ascites
fluid usingthe Econo-Pac serum IgGpurification kit from Bio-Rad Labora-
tories (Richmond, CA). Theprotocol was modified by applying 3 ml of as-
cites fluid to the DEAF Affi-gelblue column in0.028 MNaCl, 0.02 MTris,
pH 8.0, followed by 20 nil of0.028 M NaCl, 0.02 M Tris, 20 ml of 0.038 M
NaCl, 0.02 M Tris and finally, the antibody was eluted with 20 nil of
0.128 M NaCl, 0.02 MTris, pH 8.0. The antibody was at least 80% pure
as judged by SDS-PAGE (17).
The [3H]hyaluronan wasprepared by growing rat fibrosarcoma cells in
the presence of [3H]acetate as previously described (34). Themedium was
collected, digested with pronase and dialyzed extensively against distilled
water. The [3H]hyaluronan was purified by precipitation with cetylpyridin-
iumchloride followed by differential solubilization in saltsolutions(34, 39).
Theamount ofhyaluronan was determined by the uronic acid assay ofBitter
and Muir (3). The preparation of [3H]hyaluronan used in this study had a
specific activity of -6 x 104 cpm per wg of Na hyaluronan.
The fluorescein-tagged hyaluronan was prepared by mixing 200 pg
fluorescein amine, isomer 1(Aldrich, Milwaukee, WI), 200wg of 1-ethyl-3-
(3-dimethylaminopropyl) carbodiimide (Sigma Chemical Co.) and 1 mg of
hyaluronan (Healon, Pharmacia) in a final volume of 2 ml. The pH was
quickly adjusted to 4.5 and the mixture was maintained for 1 hat room tem-
perature. The reaction mixture was extensively dialyzed against 0.15 M
NaCl to remove uncoupled fluorescein amine.
Theoligosaccharide fragments ofhyaluronan were prepared by digestion
with testicular hyaluronidase followed by acid hydrolysis and reacetylation
(34). Theresulting fragments were separatedby chromatography on Sepha-
dex G-50 (34).
Protein levels were determined using the bicinchoninic acid reagent
(Pierce Chemical Co.).
Results
Degradation ofPH]Hyaluronan by Cells
In initial experiments, we examined the degradation of la-
beled [3H]hyaluronan by mouse SV3T3 cells and hamster
pulmonary macrophages, both of which are known to ex-
press the hyaluronan receptor (CD44) on their surfaces (11,
37) . The cells were cultured for 2 d in the presence of
[3H]hyaluronan and then digested extensively with pronase.
The resulting digests were examined by molecular-sieve
chromatography on a column of Sephadex G-15. As shown
in Fig. 1 (a and b), both cell types degraded the labeled
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Figure 1. The degradation of [3H]hyaluronan by SV3T3 cells and
alveolar macrophages. (a) The SV3T3 cells were cultured in 10%
NuSerum, 90% DME in the presence of 2 jg/ml [3H]hyaluronan
(4 ml total volume) . After 40 h, the medium was removed, the cell
layer was digested with pronase, recombined with the medium and
further digested. The sample was lyophilized, dissolved in 1 ml of
distilled water and applied to acolumn ofSephadex G-15 and eluted
with CMF-PBS. The background level of degradation was deter-
mined by processing a similar amount of [3H]hyaluronan in the ab-
sence ofcells. (b) Hamster alveolar macrophages were cultured in
10% FCS, 90% McCoy's medium as described above, except that
the sample size was only 1 ml. The void volume (Vo) and total vol-
ume (Vt) were determined with blue dextran 2,000 and [3H] HZO,
respectively. The elution positions of the various sized fragments
of hyaluronan were determined on subsequent chromatographic
runs and are indicated on the figure (4, tetrasaccharide fragment
of hyaluronan; 2, disaccharide fragment of hyaluronan; 1, glucu-
ronolactone; a, [3H] glucosamine).
hyaluronan as compared to control samples. The resulting
fragments ranged in size from monosaccharides to disaccha-
rides. Fragments smaller than this were not detected. These
results are consistent with those previously reported by a
number of investigators (7, 8, 25) .
To examine the time course for the degradation of hyal-
uronan in greater detail, the cells were incubated with [3H]-
hyaluronan for various periods of time, and the resulting
fragments were separated from intact [3H]hyaluronan using
Centricon 30 Microconcentrators, which gives similar results
to the molecular-sieve chromatography. As shown in Fig. 2
(a and b), while both cell types degraded the [3H]hyaluronan,
the macrophages degraded it at a much faster rate than the
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Figure 2. Time course for the
degradation of [3H]hyaluronan
by SV3T3 cells and macro-
phages. (a) SV3T3 cells were
suspended in 10% NuSerum,
90% DME and 1 ml aliquots
were distributed into a 24 multi-
well culture dish (3.3 x 106
cells per well) . (b) Alveolar
macrophages from adult ham-
sters were suspended in 10%
FCS, 90% McCoy's medium
(0.5 x 106 cells per well) and
processed as above. Toeach of
the wells was added 2 lAg of
[3H]hyaluronan (1.2 x 105
cpm), and after varying periods
oftime, the contents of the wells was digested with pronase and as-
sayed for fragments of [3H]hyaluronan using Centricon 30 Micro-
concentrators. The background (i.e., without cells) was subtracted
from each point. The error bars indicate the range ofduplicate or
triplicate determinations.
SV3T3 cells. The slopes of the initial portion of the curve
suggest that macrophages degraded hyaluronan -250 times
faster than the SV3T3 cells (1,240 cpm/h/106 for macro-
phages versus 4.8 cpm/h/106 for SV3T3 cells). Part of this
difference may be due to the fact that macrophages contain
approximately five times the amount of receptor relative to
SV3T3 cells, as determined by the [3H]hyaluronan binding
activity of detergent-solubilized cells (7,461 cpm/106 for
macrophages versus 1,447 cpm/106 for SV3T3 cells) . In
addition, SV3T3 cells synthesize hyaluronan which may
compete with the exogenously added [3H]hyaluronan, where-
as macrophages synthesize little or no hyaluronan (our un-
published observations). Despite the differences in the rate,
it is clear that both cell types have the capacity to degrade
[3H]hyaluronan.
To determine if the hyaluronan receptor (CD44) plays a
role in the degradation of hyaluronan, the effects of various
agents on this process were examined. In the case of the SV
3T3 cells (Table I), the degradation was inhibited 50-60
by both intact mAbs and Fab fragments of mAbs directed
against the hyaluronan receptor (K-3 and KM-201), whereas
control mouse IgG had little or no effect on the extent of
degradation. These results indicate that the receptor is in-
deed involved in the degradation of hyaluronan .
The effect of antibodies was even more striking in the case
of the hamster alveolar macrophages, in which the degrada-
tion was inhibited by >80% by the K-3 mAb (Table II). Fur-
ther evidence for the role of the receptor in this process is
indicated by the fact that the degradation was also blocked
by the addition of an excess of nonlabeled hyaluronan, while
the addition of other glycosaminoglycans such as dermatan
sulfate, chondroitin-4-sulfate and heparin had only a small
inhibitory effect (Table II, experiment 2) . This is in keeping
with previous studies indicating that the receptor binds with
relative specificity to hyaluronan as compared to other gly-
cosaminoglycans (35) . Along a similar line, oligosaccharide
fragments smaller than a hexasaccharide had only a modest
inhibitory effect on the degradation, which is consistent with
the size specificity for recognition by the receptor (35).
Taken together, these results strongly suggest that the
1057TableI. The Effect of Various Agents on the Degradation
ofl'3HJHyaluronan by SV-3T3 Cells
['H]Hyaluronan
Experiment
Mouse SV-3T3 cells were cultured in 1 nil of medium (10% NuSerum, 90%
DME) along with 2 jug of ['H]hyaluronan (1.2 x IUS cpm) for the indicated
period of time and then digested with pronase. The extent of ['H]hyaluronan
degradation was determined using Centricon 30 Microconcentrators as de-
scribed in Materials and Methods. The background level of degradation (i.e.,
without cells) has been subtracted from each value.
receptor (CD44) molecule is critically involved in the pro-
cess of hyaluronan degradation.
Receptor Lacks Hyaluronidase Activity
One possible explanation for the results described above is
that the receptor itself possesses hyaluronidase activity. To
investigate this possibility, membranes were isolated from
SV3T3 cells by differential centrifugation, and then in-
cubated with [3H]hyaluronan under conditions identical to
that for the intact cells. As shown in Table III, no significant
degradation of [3H]hyaluronan took place in this membrane
preparation, despite the fact that it contained more receptors
than intact cells in which degradation could be readily de-
tected. Thus, the receptor itself lacks the ability to degrade
hyaluronan.
TableIL The Effect of Various Agents on the Degradation
ofl'3HJHyaluronan by Macrophages
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Hamster alveolar macrophages in 1 ml of 10% FCS, 90% McCoy's medium
were incubated for 40 h with 2 gg of ['H]hyaluronan in the presence of the
various test substances. The extent of degradation was then determined as
described in Materials and Methods.
Table III. Binding and Degradation ofr3HJHyaluronan by
Intact SV-3T3 Cells and Membranes Preparedfrom SV-3T3
Both intact SV-3T3 cells and membranes prepared from these cells were in-
cubated with ['H]hyaluronan in 10% NuSerum, 90% DME for the indicated
periods of time. The protein content and ['H]hyaluronan binding activity
were determined both at the beginning and end of the incubation. The back-
ground levels of both the ['H]hyaluronan binding and degradation were sub-
tracted from the values shown above.
Localization ofFluorescein-tagged Hyaluronan
Another possible explanation for the above results is that the
receptor mediates the uptake of hyaluronan into the cell so
that it can be degraded internally by lysosomal enzymes. To
explore this possibility, we examined the interaction of mac-
rophages with fluorescently tagged hyaluronan. As shown in
Fig. 3 a, after incubating for only 1 min, the fluorescein-
tagged hyaluronan was bound to the surfaces of the macro-
phages. After 1 h (Fig. 3 b), the bulk of the fluorescein-
tagged hyaluronan was still present only at the cell surface.
However, after 3 h (Fig. 3 c), a small fraction of the fluores-
cence couldbe detected in granules within the macrophage.
At 24 h, most ofthe fluorescence was present in cytoplasmic
granules of varying sizes.
Both the binding and internalization of the fluorescently
tagged hyaluronan appear to involve the receptor. The K-3
mAb blocked the binding of fluorescently tagged hyaluronan
to the cell surface while control antibodies had no effect
(compare Fig. 4, b and c) . The K-3 mAb also blocked the
uptake of the fluorescein-tagged hyaluronan inside macro-
phages after a 24-h incubation (compare Fig. 4, d and e) .
Likewise, Fab fragments of the K-3 mAb inhibited both the
binding and uptake offluorescein tagged hyaluronanby mac-
rophages (data not shown). And finally, the uptake was also
inhibited by a large excess of unlabelled hyaluronan (Fig. 4
f). These results suggest that the uptake of hyaluronan is a
receptor mediated process as opposed to nonspecific phago-
cytosls.
It should be noted that the distribution of the fluorescein-
tagged hyaluronan was similar to that of the receptor. As
shown in Fig. 5 b, the receptor was present as small patches
on the cell surface as well as in granules within the
cytoplasm. This is consistent with a functional interaction
between these two components.
Degradation Blocked by Lysosomal Inhibitors
To further test the possibility that the hyaluronan was being
degraded internally by lysosomal enzymes, the effects of
chloroquine and NH4C1 were examined. These agents pre-
vent the acidification of endocytotic vesicles and thereby in-
hibit the enzymatic activity of acid hydrolases (5, 6, 21). As
shown in Table IV, both of these agents significantly in-
hibited the degradation of ['H]hyaluronan by alveolar mac-
rophages. These results suggest that the degradation of
1058
Experiment
No. Treatment
['H]Hyaluronan
Concentration Degraded Inhibition
uglml cpm t range %
1 Control 0 4,976 t 174 0
Mouse IgG 20 5,224 f 196 -5
K-3 20 468 t 100 91
Hyaluronan 200 242 t 122 95
2 Control 0 3,706 f 400 0
Mouse IgG 20 3,142 t 1,004 15
K-3 20 644 t 218 83
Hyaluronan 100 206 t 280 94
Dermatan Sulfate 100 2,520 t 164 32
Chondroitin-4-Sulfate 100 2,498 t 374 33
Heparin 100 2,416 t 240 35
Disaccharide 100 2,998 t 74 19
Tetrasaccharide 100 2,252 f 122 39
Hexasaccharide 100 1,736 t 114 53
No. Time
h
Treatment Concentration
uglml
Degraded
cpm t range
Inhibition
%
1 40 Control 0 500 f 71 0
40 Mouse IgG 20 600 f 91 -20
40 K-3 20 248 f 63 50
40 Fab K-3 20 220 t 76 56
2 20 Control 0 391 t 44 0
20 Mouse IgG 20 359 t 25 8
20 KM-201 20 154 t 34 61
Sample Time
h
Protein
ug
['H]Hyaluronan
binding
cpm f range
Specific
activity
cpmlug
['H]Hyaluronan
degraded
cpm f range
Intact Cells 0 810 4,776 t 512 5.9 26 f 7
20 895 5,931 t 321 6 .6 391 f 44
Membranes 0 61 10,706 t 1,326 175 .5 30 f 21
40 42 6,038 f 518 143.8 37 t 22Figure 3. The binding and uptake of fluorescein-tagged hyaluronan by hamster alveolar macrophages . The macrophages were incubated
with tagged hyaluronan for various periods of time and then examined under the fluorescent microscope as described in Materials and
Methods . (a) At 1 min, the fluorescein-tagged hyaluronan was present only on the surface ofthe macrophage. (b) At 1 h, the tagged hyal-
uronan was still restricted to the cell surface. (c) After 3 h, a fraction of the tagged hyaluronan could be observed in intracellular granules .
(d) After 24 h, the bulk of the hyaluronan was present inside the macrophage in both large granules and granules which are at the limit
of resolution of the microscope. Bar, 10 /m .
[ 3H]hyaluronan takes place in the lysosomal compartments
of the cell .
Discussion
The results ofthis study indicate that the hyaluronan receptor
(CD44) plays a key role in the degradation of hyaluronan .
More specifically, the receptor is responsible for the initial
binding of hyaluronan to the cell surface so that it can be in-
ternalized and degraded by acid hydrolases . Thus, the degra-
dation of hyaluronan takes place in a fashion similar to that
of other receptor-mediated degradatory processes such as
LDL and transferrin (10) .
The degradation of hyaluronan appears to involve three
distinct steps : first, it binds the cell surface ; second, it is en-
docytosed ; and third, it is degraded by acid hydrolases . In
the first step, the receptor mediates the attachment of hyal-
uronan to the cell surface, as previously demonstrated by the
fact that mAbs to the receptor block the binding of [ 3H]hy-
aluronan to the cell surface (12), and further confirmed
in the present study with fluorescein tagged hyaluronan .
Clearly, this step is critical in the degradatory process, since
blockage of this step also inhibits the subsequent steps lead-
ing to the breakdown of hyaluronan .
The second step involves the uptake of hyaluronan into the
cells . This process could be directly visualized with the
fluorescein tagged hyaluronan, which revealed that it was
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taken up into granules of varying sizes . More importantly,
this uptake was blocked by themAbs to the receptor as well
as by an excess of nonlabeled hyaluronan, suggesting that it
is a receptor-mediated process as opposed to nonspecific
phagocytosis . This receptor-mediated uptake is consistent
with previous studies suggesting that the receptor is as-
sociated with the cytoskeleton (15, 16) .
In the third step, the hyaluronan is degraded by lysosomal
enzymes . This was indirectly suggested by the fact that the
receptor itself lacked hyaluronidase activity, since isolated
membranes ofSV3T3 cells enriched in the receptor did not
have the capacity to degrade [3H]hyaluronan . More direct
evidence for the role of lysosomal enzymes in this process
came from the fact that the degradation of [ 3H]hyaluronan
was inhibited by chloroquine and NH 4C1, both of which
prevent the acidification of the lysosomal compartment re-
quired for the action of lysosomal enzymes (5, 6, 21) . These
results are consistent with previous studies which have
reported that a number of different cell types contain acid
hydrolases which are capable of degrading hyaluronan (8,
24,27) .
The findings of this study are also in keeping with the ear-
lier studies of Orkin and her coworkers (20, 24, 25), who
showed that the rate limiting step for the degradation of
hyaluronan was its internalization . Furthermore, several
characteristics of the degradation process were consistent
with the role of thehyaluronan receptor in this process . First,
1059Figure 4. The effect of various agents on the binding of fluorescein-tagged hyaluronan to macrophages after 3 and 24 h. (a) Macrophages
incubated in the absence of fluorescein tagged hyaluronan show the background level of fluorescence . (b) Macrophages pretreated with
control mouse IgG (20 ug/ml) and then incubated with fluorescein-tagged hyaluronan (100 mg/ml) for 3 h show fluorescence both on the
cell surface and intracellularly. (c) Macrophages pretreated with the K-3 mAb (20 pg/ml) and then incubated with fluorescein-tagged
hyaluronan show a lower level of fluorescence . (d) Macrophages incubated with tagged hyaluronan for 24 h demonstrate the presence of
fluorescence predominantly in cytoplasmic granules . (e) Macrophages pretreated with the K-3 mAb followed by a 24-h incubation with
tagged hyaluronan show a greatly diminished level offluorescence. (f) Macrophages premixed with nonlabeled hyaluronan (1 mg/ml) and
then incubated with the tagged hyaluronan for 24 h, show that most of the uptake is blocked . The photography and processing within
sets a-c and d-fwere carried out under identical conditions . Bar, 10 jm .
SV3T3 cells degraded [ 3H]hyaluronan at a much faster rate
than 3T3 cells (25), which correlates with the fact that they
have a greater number of receptors available on their sur-
faces (40) . And secondly, larger molecules of hyaluronan
were degraded more readily than smaller molecules (20) .
This size-dependence was also one of the characteristic fea-
tures ofhyaluronan binding to the cell surface receptor (36) .
A number ofstudies have shown that liver endothelial cells
also degrade hyaluronan (7, 18, 26) . However, this does not
appear to involve the hyaluronan receptor (CD44), since im-
munohistochemical studies have indicated that the receptor
is absent from these cells of adult hamsters or mice (unpub-
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lished observations) . Furthermore, the characteristics of
hyaluronan binding to endothelial cells are different from
that of theCD44 with respect to both oligosaccharide recog-
nition (18) and size dependency of the interaction (8) . It is
possible that a different type of hyaluronan binding protein
is present on liver endothelial cells, which carries out a simi-
lar type of function . Indeed, a number of other hyaluronan
binding proteins have been described .
The ability of cells expressing the receptor to degrade
hyaluronan may have a number of important biological con-
sequences. For example, macrophages probably function to
degrade hyaluronan from connective tissues of the adult .
1060Figure S. The distribution of the hyaluronan receptor on macrophages . (a) The background level of fluorescence in shown (i.e., b-K-3
mAb omitted) . (b) The pattern of fluorescence observed with b-K-3 mAb followed by FITC-Streptavidin . The receptor is present on the
cell surface as well as in cytoplasmic granules . Bar, 10 /Am .
This may be particularly important in the case of the lung,
where hyaluronan on the surfaces of alveoli could interfere
with air-blood exchange .
Dendritic cells represent another family of cells (29) that
is involved in the turn-over of hyaluronan . Fraser and co-
workers (8, 9) have shown that when [ 3H]hyaluronan was
injected either intravenously or into afferent lymphatic ves-
sels, a large fraction was removed by dendritic cells of the
spleen and lymph nodes . Histochemical studies have indi-
cated that dendritic cells express large amounts of the recep-
tor (CD44) (our unpublished observations) . Furthermore,
the characteristics of the removal of [ 3H]hyaluronan by
lymphatic tissue were consistent with the involvement of the
hyaluronan receptor (CD44) with regard to specificity of the
binding and the size dependency.
The receptor-mediated degradation of hyaluronan may be
an important factor during cell migration . For example, the
ability ofmacrophages to degrade hyaluronanmay be impor-
tant during the process of migration through the extracellular
matrix . Along similar lines, many tumor cells degrade the
matrix through which they migrate as part of the invasive
process . A number of proteases have been described in tu-
mor cells which hydrolyze collagen, fibronectin and laminin .
It is possible that these cells may also degrade hyaluronan .
Recently, Gunthert et al . (13) have shown that the expression
of a high molecular weight form of CD44 is directly cor-
Table IV . Effect ofAcidotropic Agents ofPHJHyaluronan
Degradation by Macrophages
['H]Hyaluronan
Agent Concentration Degraded Inhibition
M
￿
cpm t range
Control
￿
0
￿
1,394 t 46
￿
0
Chloroquine
￿
1 x 10-5
￿
978 t 20
￿
30
5 x 10-5
￿
80 t 34
￿
94
1 x 10-4
￿
8 t 20
￿
99
NH4C1
￿
1 x 10-'
￿
726 t 86
￿
48
1 x 10-1
￿
44 f 2
￿
97
Hamster alveolar macrophages were preincubated with the test substances for
20 minand then further incubated for 6 h in the presence of [3H]hyaluronan .
The background level of 1°H]hyaluronan degradation was subtracted from
each value .
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related with the metastatic properties of cells . Indeed, non-
metastatic cells were converted to metastatic cells by trans-
fecting them with cDNA of this form ofCD44 (13) . It would
be interesting to determine if this form ofCD44 has the ca-
pacity to bind hyaluronan .
The turnover of hyaluronan is also important during em-
bryonic development . In a series ofstudies, Toole and his as-
sociates (31) have shown that hyaluronan changes in a dy-
namic fashion during the development of a number oftissues
(cornea, brain, limb bud, etc .) . During early developmental
stages, these tissues contain relatively large amount of
hyaluronan, which functions to keep cells separated, so that
cell migration and other morphological events can take
place . Then, at a defined stage, the concentration of hyaluro-
nan is abruptly reduced, leading to the condensation of the
tissue . It is possible that the hyaluronan receptor participates
in this developmentally programmed loss ofhyaluronan . In-
deed, recently we have found that the expression of the
receptor coincides with the stages during which the hyaluro-
nan is removed (our unpublished observations) .
In conclusion, our results suggest that CD44 is responsi-
ble for the receptor-mediated uptake of hyaluronan leading
to its degradation . In view ofhyaluronaifs widespread distri-
bution and importance in connective tissue, it is reasonable
that this mechanism has evolved to facilitate its removal .
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